SB 142-INSURANCE FOR ANTI-CANCER MEDICATION                                                                       
                                                                                                                                
[Due to technical  difficulties, the record from  4:49:46 p.m. to                                                               
4:51:39  p.m. was  reconstructed from  the recording  secretary's                                                               
log notes.]                                                                                                                     
                                                                                                                                
4:49:46 PM                                                                                                                    
                                                                                                                                
CHAIR OLSON announced  that the final order of  business would be                                                               
CS  FOR  SENATE  BILL  NO.  142(L&C)  am,  "An  Act  relating  to                                                               
insurance coverage for anti-cancer medications."                                                                                
                                                                                                                                
[During  the   meeting  of  4/6/16,  Amendment   1,  labeled  29-                                                               
LS1133\W.A.1, Wallace, 4/5/16, was  objected to by Representative                                                               
LeDoux.  Amendment 1 read:                                                                                                      
                                                                                                                                
     Page 1, line 1, following "medications":                                                                                 
          Insert "; and providing for an effective date"                                                                      
                                                                                                                                
     Page 2, following line 14:                                                                                                 
          Insert a new bill section to read:                                                                                    
          "* Sec. 3. This Act takes effect January 1,                                                                         
     2017."]                                                                                                                    
                                                                                                                                
[Chair  Olson stated  that  he  objected to  Amendment  1 at  the                                                               
previous hearing.]                                                                                                              
                                                                                                                                
REPRESENTATIVE  JOSEPHSON asked  Ms. Wing-Heier  to elaborate  on                                                               
her  previous testimony  regarding  an individual's  choice of  a                                                               
pharmacy.                                                                                                                       
                                                                                                                                
4:51:51 PM                                                                                                                    
                                                                                                                                
LORI WING-HEIER,  Director, Division of Insurance,  Department of                                                               
Commerce,  Community &  Economic  Development (DCCED),  explained                                                               
that if  an individual goes  to a pharmacy  [out-of-network] they                                                               
will receive a  higher copay, which is how the  plans are written                                                               
within the individual's plan.                                                                                                   
                                                                                                                                
REPRESENTATIVE JOSEPHSON  observed that an individual  may choose                                                               
to go to an alternate pharmacy but would risk paying more.                                                                      
                                                                                                                                
MS. WING-HEIER agreed  and stated that if  the individual chooses                                                               
to go  to a pharmacy out-of-network,  just as they may  choose to                                                               
go to a physician out-of-network, there would be a higher copay.                                                                
                                                                                                                                
REPRESENTATIVE JOSEPHSON  referred to  the effective date  of the                                                               
bill,  and  recalled  testimony  regarding  the  urgency  of  the                                                               
application  if  the bill  becomes  law,  such as  administrative                                                               
problems associated  with the bill.   He asked  for clarification                                                               
of the effective date shown on page 2, line 12.                                                                                 
                                                                                                                                
MS. WING-HEIER explained  that the division must  comply with the                                                               
effective  date of  the [Patient  Protection and  Affordable Care                                                               
Act  of 2010  (PPACA)],  and  most of  the  plans  now are  dated                                                               
January 1.   Therefore, the form filings and such  have to be May                                                               
11, although  they can  be amended up  until mid-August,  but the                                                               
first form  filings are due  for the 2017 plans  on May 11.   The                                                               
division is beginning  to receive form filings  that are affected                                                               
by this and  other pending bills, thus the  division is "squeezed                                                               
into  this 30-day  period for  bills that  haven't passed,  to be                                                               
signed, to go  to the insurers, to be [put]  into plan documents,                                                               
to be  filed with ...  the division,  to be approved,  and that's                                                               
the,  the  administrative  heartache  that  we're  asking  for  a                                                               
revised effective date."                                                                                                        
                                                                                                                                
4:53:50 PM                                                                                                                    
                                                                                                                                
CHAIR  OLSON  removed  his  objection to  Amendment  1  [and  the                                                               
committee treated the objection  made by Representative LeDoux as                                                               
withdrawn.]   There being no  further objection, Amendment  1 was                                                               
adopted.                                                                                                                        
                                                                                                                                
CHAIR  OLSON opened  public testimony  and after  ascertaining no                                                               
one wished to testify, closed public testimony.                                                                                 
                                                                                                                                
4:54:34 PM                                                                                                                    
                                                                                                                                
REPRESENTATIVE TILTON  moved to  report the  committee substitute                                                               
for CSSB  142(L&C)am, Version 29-LS1133\W.A,  as amended,  out of                                                               
committee  with individual  recommendations and  the accompanying                                                               
zero fiscal notes.   There being no objection,  HCS CSSB 142(L&C)                                                               
was  reported  out  of  the House  Labor  and  Commerce  Standing                                                               
Committee.